The overall objective is to give every child the opportunity to enter into a clinical trial and have access to the most advanced/innovative care option.
Insulin pumps have become more advanced over the years and the current generation on the market are designed to reduce hypoglycaemia, and increase time spent in the desired range.
Hybrid closed loop systems are made up of an insulin pump, continuous glucose monitor and a maths program or algorithm. The algorithm collects data from both the insulin pump and the continuous glucose monitor and then triggers the insulin pump to adjust the insulin dose automatically in an effort to maintain target blood glucose levels. This is an exciting and rapidly advancing area of research.
Much of our research as part of the Artificial Pancreas Consortium focuses on the safety and the use of these emerging technologies.
Find out more about our technology research team and what they are working on below.
Current studies
Closed Loop and Education for hypoglycemia Awareness Restoration
Evaluation of the DS5 performance over a fifteen-day wear period
Revisiting hypoglycaemia management in children with T1D on contemporary therapy (Hypo survey)
Redefining glucose thresholds for Hypo management in children with T1D on closed loop therapy: a cross-over clinical trial (Hypo RCT)